Fosfomycin in the GP’s office – therapeutic signposts Review article
Article Sidebar
Published:
Sep 29, 2023
Keywords:
infection, urinary tract, fosfomycin
Main Article Content
Abstract
The paper presents the basic principles of treatment of simple, uncomplicated urinary tract infections. The important role and therapeutic efficacy of fosfomycin is indicated. Several clinical cases indicating its correct use are discussed and various situations allowing for therapy with this antibiotic are shown.
Article Details
How to Cite
Sapilak , B. J. (2023). Fosfomycin in the GP’s office – therapeutic signposts. Medycyna Faktow (J EBM), 16(3(60), 392-396. https://doi.org/10.24292/01.MF.0323.20
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Bermingham S, Ashe J. Systematic review of the impact of urinary tract infections on health-related quality of life. BJUI. 2012; 110: 830-6.
2. Bent S, Nallamothu BK, Simel DL et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002; 287: 2701-10.
3. Qiao LD, Chen S, Yang Y et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open. 2013; 3: e004152. http://doi.org/10.1136/bmjopen-2013-004152.
4. Bonkat G., Bartoletti R., Bruyère F et al. EAU Guidelines on Urological Infections (access: 17.08.2023).
5. Hooton T. Urinary tract infection in adults. In: Floege J, Johnson R, Feehally J (ed). Comprehensive Clinical Nephrology (5th ed). Elsevier/Saunders, Philadelphia, PA 2015.
6. Hryniewicz W, Holecki M, Duława J et al. Rekomendacje diagnostyki, terapii i profilaktyki zakażeń układu moczowego u dorosłych (access: 17.08.2023).
7. Polat M, Ozkaya-Parlakay A, Tapısız A et al. Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents. J Chemother. 2022; 34(2): 97-102. http://doi.org/10.1080/1120009X.2021.1955203.
8. Barr WH, Lin CC, Radwanski E et al. The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis. 1991; 14: 93-100.
9. Naber KG, Schitob G, Bottoc H et al. Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy. Eur Urol. 2008; 54 (5): 1164-78.
10. Grabe M, Bartoletti R, Bjerklund Johansen TE et al. Guideliness on urological infections. European Association of Urology 2015 (access: 17.08.2023).
11. Możdżan M, Loba J, Ruxer J et al. The Efficacy of Chronic Therapy of Recurrent Lower Urinary Tract Infections with Fosfomycin and Nitrofurantoin in Type 2 Diabetic Patients. Adv Clin Exp Med. 2007; 16(6): 777-84.
12. Jido TA. Urinary Tract Infections in Pregnancy: Evaluation of Diagnostic Framework. Saudi J Kidney Dis Transpl. 2014; 25(1): 85-90.
2. Bent S, Nallamothu BK, Simel DL et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002; 287: 2701-10.
3. Qiao LD, Chen S, Yang Y et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open. 2013; 3: e004152. http://doi.org/10.1136/bmjopen-2013-004152.
4. Bonkat G., Bartoletti R., Bruyère F et al. EAU Guidelines on Urological Infections (access: 17.08.2023).
5. Hooton T. Urinary tract infection in adults. In: Floege J, Johnson R, Feehally J (ed). Comprehensive Clinical Nephrology (5th ed). Elsevier/Saunders, Philadelphia, PA 2015.
6. Hryniewicz W, Holecki M, Duława J et al. Rekomendacje diagnostyki, terapii i profilaktyki zakażeń układu moczowego u dorosłych (access: 17.08.2023).
7. Polat M, Ozkaya-Parlakay A, Tapısız A et al. Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents. J Chemother. 2022; 34(2): 97-102. http://doi.org/10.1080/1120009X.2021.1955203.
8. Barr WH, Lin CC, Radwanski E et al. The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis. 1991; 14: 93-100.
9. Naber KG, Schitob G, Bottoc H et al. Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy. Eur Urol. 2008; 54 (5): 1164-78.
10. Grabe M, Bartoletti R, Bjerklund Johansen TE et al. Guideliness on urological infections. European Association of Urology 2015 (access: 17.08.2023).
11. Możdżan M, Loba J, Ruxer J et al. The Efficacy of Chronic Therapy of Recurrent Lower Urinary Tract Infections with Fosfomycin and Nitrofurantoin in Type 2 Diabetic Patients. Adv Clin Exp Med. 2007; 16(6): 777-84.
12. Jido TA. Urinary Tract Infections in Pregnancy: Evaluation of Diagnostic Framework. Saudi J Kidney Dis Transpl. 2014; 25(1): 85-90.